Skip to content

Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection

Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00583466
Enrollment
18
Registered
2007-12-31
Start date
2007-05-31
Completion date
2008-05-31
Last updated
2017-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Large Polyps in the Gastrointestinal Tract

Keywords

submucosal cushion, polypectomy, endoscopic mucosal resection

Brief summary

For removal of large flat lesions of the gastro-intestinal tract injection of a solution under the lesion creates a safety cushion and protects from damage to the gastrointestinal tract wall. Various solutions are currently used, but some of them are easy to inject but quickly dissipate (normal saline),other solutions are more longer lasting (hydroxypropyl methylcellulose, hyaluronic acid, etc) but are very difficult to inject and can be expensive and not always available. The investigators performed previously animal experiments which demonstrated that blood is easy to inject and creates a protective cushion which lasts longer than other fluids which are currently used for protective cushion creation.

Detailed description

For removal of large flat lesions of the gastro-intestinal tract injection of a solution under the lesion creates a safety cushion and protects from damage to the gastrointestinal tract wall. Various solutions are currently used, but some of them are easy to inject but quickly dissipate (normal saline),other solutions are more longer lasting (hydroxypropyl methylcellulose, hyaluronic acid, etc) but are very difficult to inject and can be expensive and not always available. The investigators decided to use blood drawn from the patient for injection under the lesion. The investigators performed previously animal experiments which demonstrated that blood is easy to inject and creates a protective cushion which lasts longer than other fluids which are currently used for protective cushion creation. Blood can also have local hemostatic action preventing from bleeding during polypectomy.

Interventions

Autologous blood will be drawn from the patient and then reinjected under the lesion to create a safety cushion

DRUGNormal saline

Normal saline will be injected under the lesion to create submucosal cushion

DRUGHPMC

Hydroxypropyl methylcellulose (HPMC) will be injected under the lesion to create submucosal cushion

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Polyps equal or larger than 1 cm

Exclusion criteria

* Coagulopathy * Inability to sign informed consent

Design outcomes

Primary

MeasureTime frame
Duration of the Submucosal CushionImmediately after the procedure, Up to 5 minutes

Countries

United States

Participant flow

Recruitment details

No data on how participants were randomized, and no further baseline data (other than categorical age and sex) are available for this record. The PI has left the institution and has been contacted. Per the PI the data are no longer available and the study has not been published.

Participants by arm

ArmCount
All Participants
Polypectomy with normal saline injected for submucosal cushion creation Normal saline: Normal saline will be injected under the lesion to create submucosal cushion OR Polypectomy after injection of hydroxypropyl methylcellulose (HPMC) to create submucosal cushion HPMC: Hydroxypropyl methylcellulose (HPMC) will be injected under the lesion to create submucosal cushion OR Polypectomy after injection of autologous blood Autologous blood injection: Autologous blood will be drawn from the patient and then reinjected under the lesion to create a safety cushion
18
Total18

Baseline characteristics

CharacteristicAll Participants
Age, Customized
>= 18, <= 90
18 Participants
Region of Enrollment
United States
18 participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 18
other
Total, other adverse events
0 / 18
serious
Total, serious adverse events
0 / 18

Outcome results

Primary

Duration of the Submucosal Cushion

Time frame: Immediately after the procedure, Up to 5 minutes

Population: No data is available for this record. The PI has left the institution and has been contacted. Per the PI the data is no longer available and the study has not been published.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026